Abstract
The mechanism of action as well as the clinical effects of thyroid hormones on bone has been of interest for more than a century. With the appearance of new treatment modalities for thyroid function disorders, the accompanying alterations in bone metabolism appeared to be rare. However, the introduction of new diagnostic tools, such as osteodensitometry and biochemical bone markers, has changed our view since they were able to show smaller but important changes in bone mineral metabolism associated with thyroid function disorders. Now, we know that hyperthyroidism is associated with an increased life-time risk for fractures, even after achieving euthyroidism. This fact may play an important role in the higher mortality rate among previously hyperthyroid patients later in life. Subclinical hyperthyroidism may also affect bone density, however, its effect on fracture rate remains to be established. The lack of thyroid hormones will alter normal growth during childhood. Adult hypothyroid patients tend to exhibit higher than normal bone density. Despite rather increased bone quantity, hypothyroidism is accompanied with increased fracture risk before and after diagnosis. The effect of thyroid hormone treatment on bone tissue is somewhat controversial. Nevertheless, only patients with suppressed thyroid-stimulating hormone (TSH) appear to loose bone and have higher fracture incidence, whereas patients with a TSH level in the normal range seem to have similar bone mineral content and fracture rate as euthyroid subjects. In summary, most of thyroid function disorders may result in reduced bone density and/or increased fracture rate that should be taken into consideration at clinical evaluation.
Similar content being viewed by others
References
R Rizzoli J Poser U Bürgi (1986) ArticleTitleNuclear thyroid hormone receptors in cultured bone cells. Metabolism 35 71–74 Occurrence Handle1:CAS:528:DyaL28XhtF2k
K Sato DC Han Y Fujii T Tsushima K Shizume (1987) ArticleTitleThyroid hormone stimulates alkaline phosphatase activity in cultured rat osteoblastic cells (ROS 17/2.8) through 3,5,3′-triiodo-L-thyronine nuclear receptors. Endocrinology 120 1873–1881 Occurrence Handle1:CAS:528:DyaL2sXitVyitbs%3D Occurrence Handle3569118
EO Abu S Bord A Horner VKK Chatterjee JE Compston (1997) ArticleTitleThe expression of thyroid hormone receptors in human bone. Bone 21 137–142 Occurrence Handle10.1016/S8756-3282(97)00097-5 Occurrence Handle1:CAS:528:DyaK2sXlvV2qt7c%3D Occurrence Handle9267688
JM Britto AJ Fenton WR Holloway GC Nicholson (1994) ArticleTitleOsteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 134 169–176 Occurrence Handle1:CAS:528:DyaK2cXps1Gmtw%3D%3D Occurrence Handle8275930
A Fraichard O Chassande M Plateroto et al. (1997) ArticleTitleThe T3R alpha gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production. Embo J 16 4412–4420 Occurrence Handle10.1093/emboj/16.14.4412 Occurrence Handle1:CAS:528:DyaK2sXkvFeqtbc%3D Occurrence Handle9250685
K Gauthier M Plateroti CB Harvey et al. (2001) ArticleTitleGenetic analysis reveals different functions for the products for thyroid hormone receptor alpha locus. Mol Cell Biol 21 4746–4748 Occurrence Handle10.1128/MCB.21.14.4748-4760.2001
D Forrest LC Erway L Mg R Altschuler T Curran (1996) ArticleTitleThyroid hormone receptor beta is essential for development of auditory function. Nat Genet 13 354–357 Occurrence Handle1:CAS:528:DyaK28XktVegtL8%3D Occurrence Handle8673137
GR Mundy JL Shapiro JG Bandelin EM Canalis LG Raisz (1976) ArticleTitleDirect stimulation of bone resorption by thyroid hormones. J Clin Invest 58 529–534 Occurrence Handle1:CAS:528:DyaE28XlsFCht7c%3D Occurrence Handle182721
P Lakatos PH Stern (1992) ArticleTitleEffects of cyclosporins and transforming growth factor beta on thyroid hormone action in cultured fetal rat limb bones. Calcified Tissue Int 50 123–128 Occurrence Handle1:CAS:528:DyaK38Xhs1Kktr8%3D
G Tarjan PH Stern (1995) ArticleTitleTriiodothyronine potentiates the stimulatory effects of interleukin-l < beta > on bone resorption and medium interleukin-6 content in fetal rat limb bone cultures. J Bone Miner Res 10 1321–1326 Occurrence Handle1:CAS:528:DyaK2MXotlyhtr4%3D Occurrence Handle7502703
P Lakatos J Foldes C Horvath L Kiss A Tatrai I Takacs G Tarjan PH Stern (1997) ArticleTitleSerum IL-6 and bone metabolism in patients with thyroid function disorders. J Clin Endocrinol Metab 82 78–81 Occurrence Handle1:CAS:528:DyaK2sXkt1Snug%3D%3D Occurrence Handle8989237
P Lakatos MD Caplice V Khanna PH Stern (1993) ArticleTitleThyroid hormones increase insulin-like growth factor-I content in the medium of rat bone tissue. J Bone Miner Res 8 1475–1481 Occurrence Handle1:CAS:528:DyaK2cXivFSmsr8%3D Occurrence Handle8304049
P Lakatos J Foldes Z Nagy I Takács G Speer C Horváth S Mohan DJ Baylink PH Stern (2000) ArticleTitleSerum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism. Thyroid 5 417–423
E Svanberg J Healey D Mascarenhas (2001) ArticleTitleAnabolic effects of rhIGF-I/IGFBP-3 in vivo are influenced by thyroid status. Eur J Clin Invest 31 IssueID4 329–336 Occurrence Handle10.1046/j.1365-2362.2001.00793.x Occurrence Handle1:CAS:528:DC%2BD3MXjsVSjuro%3D Occurrence Handle11298780
DA Stevens RP Hasserjian H Robson T Siebler SM Shalet GR Williams (2000) ArticleTitleThyroid hormones regulate hypertrophic chondrocyte differentiation and expression of parathyroid hormone-related peptide and its receptor during endochondral bone formation. J Bone Miner Res 15 IssueID12 2431–2442 Occurrence Handle1:CAS:528:DC%2BD3cXovVShsL8%3D Occurrence Handle11127207
M Miura K Tanaka Y Komatsu M Suda A Yasoda Y Sakuma A Ozasa K Nakao (2002) ArticleTitleThyroid hormones promote chondrocyte differentiation in mouse ATDC5 cells and stimulate endochondral ossification in fetal mouse tibias through iodothyronine deiodinases in the growth plate. J Bone Miner Res 17 IssueID3 443–454 Occurrence Handle1:CAS:528:DC%2BD38XitVKht7g%3D Occurrence Handle11874236
SH Toh BC Claunch PH Brown (1985) ArticleTitleEffect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med 145 833–886
SA Fraser JB Anderson DA Smith GM Wilson (1971) ArticleTitleOsteoporosis and fractures following thyrotoxicosis. Lancet 1 981–983 Occurrence Handle1:STN:280:CS6C1crpt10%3D Occurrence Handle4102450
PJ Meunier GGS Bianchi CM Edouard (1972) ArticleTitleBone manifestations of thyrotoxicosis. Orthop Clin North Am 3 745–774
EF Eriksen (1986) ArticleTitleNormal and pathological remodeling of human trabecular bone: three-dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocr Rev 7 379–408 Occurrence Handle1:STN:280:BiiD2MzntVU%3D Occurrence Handle3536460
L Mosekilde EF Eriksen P Charles (1990) ArticleTitleEffects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19 35–63
B Jastrup L Mosekilde F Melsen B Lund B Lund OH Sorensen (1982) ArticleTitleSerum levels of vitamin D metabolites and bone remodeling in hyperthyroidism. Metabolism 31 126–132 Occurrence Handle1:CAS:528:DyaL38XkvF2rtg%3D%3D Occurrence Handle6978987
DS Cooper MM Kaplan EC Ridgway F Maloof GH Daniels (1979) ArticleTitleAlkaline phosphatase isoenzyme patterns in hyperthyroidism. Ann Intern Med 90 164–168 Occurrence Handle1:CAS:528:DyaE1MXhtF2htLk%3D Occurrence Handle582089
DR Garrel PD Delmas L Malaval J Tournaire (1986) ArticleTitleSerum bone Gla protein: a marker of bone turnover in hyperthyroidism. J Clin Endocrinol Metab 62 1052–1055 Occurrence Handle1:STN:280:BimC28fntFw%3D Occurrence Handle3485649
JM MacLeod KC McHardy RD Harvey A Duncan IW Reid PD Bewsher SP Robins (1993) ArticleTitleThe early effects of radioiodine therapy for hyperthyroidism on biochemical indices of bone turnover. Clin Endocrinol 38 49–53 Occurrence Handle1:STN:280:ByyC28bnslw%3D
HE Nielsen L Mosekilde P Charles (1979) ArticleTitleBone mineral content in hyperthyroid patients after combined medical and surgical treatment. Acta Radiol Oncol Radiat Phys Biol 18 122–128 Occurrence Handle1:STN:280:Bi%2BD3sfpvVQ%3D Occurrence Handle495190
J Linde T Friis (1979) ArticleTitleOsteoporosis in hyperthyroidism estimated by photon absorptiometry. Acta Endocrinol 91 437–448 Occurrence Handle1:STN:280:CSaB2M7psVI%3D Occurrence Handle474036
B Krolner JV Jorgensen SP Nielsen (1983) ArticleTitleSpinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment. Clin Endocrinol 18 439–446 Occurrence Handle1:STN:280:BiyB2MbnvFA%3D
CJ Rosen RA Adler (1992) ArticleTitleLongitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J Clin Endocrinol Metab 75 1531–1534 Occurrence Handle1:STN:280:ByyC3c%2FjvFc%3D Occurrence Handle1464660
DJ Grant MET McMurdo PA Mole CR Paterson (1995) ArticleTitleIs previous hyperthyroidism still a risk factor for osteoporosis in post-menopausal women? Clin Endocrinol 43 339–345 Occurrence Handle1:STN:280:BymD2cnosF0%3D
BL Langdahl AG Loft EF Eriksen L Mosekilde P Charles (1996) ArticleTitleBone mass, bone turnover, calcium homeostasis, and body composition in surgically and radioiodine-treated former hyperthyroid patients. Thyroid 6 169–175 Occurrence Handle1:STN:280:BymH3svjsFE%3D Occurrence Handle8837322
BL Langdahl AG Loft EF Eriksen L Mosekilde P Charles (1996) ArticleTitleBone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy. Thyroid 6 161–168 Occurrence Handle1:STN:280:BymH3svjsFA%3D Occurrence Handle8837321
T Diamond J Vine R Smart P Butler (1994) ArticleTitleThyrotoxic bone disease in women: a potentially reversible disorder. Ann Intern Med 120 8–11 Occurrence Handle1:STN:280:ByuD2s7jtlU%3D Occurrence Handle8250460
SR Cummings MC Nevitt WS Browner K Stone KM Fox KE Ensrud J Cauley D Black TM Vogt (1995) ArticleTitleRisk factors for hip fracture in white women. N Engl J Med 332 767–773 Occurrence Handle1:STN:280:ByqC28nislE%3D Occurrence Handle7862179
B Wejda G Hintze B Katschinski T Olbricht G Benker (1995) ArticleTitleHip fractures and the thyroid: a case control study. J Intern Med 237 241–247
DC Bauer B Ettinger MC Nevitt KL Stone (2001) ArticleTitleRisk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134 561–568 Occurrence Handle1:CAS:528:DC%2BD3MXivVaju7c%3D Occurrence Handle12803168
P Vestergaard L Rejnmark J Weeke L Mosekilde (2000) ArticleTitleFracture risk in patients treated for hyperthyroidism. Thyroid 10 341–348 Occurrence Handle1:STN:280:DC%2BD3c3msFensQ%3D%3D Occurrence Handle10807063
JA Franklyn P Maisonneuve MC Sheppard J Betteridge P Boyle (1998) ArticleTitleMortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 338 712–718 Occurrence Handle10.1056/NEJM199803123381103 Occurrence Handle1:CAS:528:DyaK1cXitFarsrc%3D Occurrence Handle9494147
J Faber IW Jensen L Petersen B Nygaard L Hegedus K Siersback-Nielsen (1998) ArticleTitleNormalization of serum thyrotropin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women. Clin Endocrinol 48 285–290 Occurrence Handle10.1046/j.1365-2265.1998.00427.x Occurrence Handle1:CAS:528:DyaK1cXisVKnur0%3D
AH Mudde AJ Houben AC Nieuwenhuijzen-Kruseman (1994) ArticleTitleBone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism. Clin Endocrinol 41 421–424 Occurrence Handle1:STN:280:ByqD2czks1E%3D
J Foldes G Tarján M Szathmari F Varga I Krasznai (1993) ArticleTitleBone mineral density in patients with endogenous subclinical hyperthyroidism: Is this thyroid status a risk factor for osteoporosis? Clin Endocrinol 39 521–527 Occurrence Handle1:STN:280:ByuD2svhsVc%3D
AH Mudde FJL Reijnders AC Nieuwenhuijze-Kruseman (1992) ArticleTitlePeripheral bone density in women with untreated multinodular goitre. Clin Endocrinol 37 35–39 Occurrence Handle1:STN:280:ByyD2cjjslE%3D
Y Kumeda M Inaba H Tahar Y Kunoka T Ishikawa H Morii Y Nishizawa (2000) ArticleTitlePersistent increase in bone turnover in Graves’ patients with subclinical hyperthyroidism [in process citation]. J Clin Endocrinol Metab 85 4157–4161 Occurrence Handle1:CAS:528:DC%2BD3cXotlWnurY%3D Occurrence Handle11095447
JM Stock MI Surks JH Oppenheimer (1974) ArticleTitleReplacement dosage of L-thyroxine in hypothyroidism. N Engl J Med 290 529–533 Occurrence Handle1:STN:280:CSuD1cjltVY%3D Occurrence Handle4811096
TL Paul J Kerrigan AM Kelly DT Braverman, Baran (1988) ArticleTitleLong-term L-thyroxine is associated with decreased hip bone density in premenopausal women. JAMA 259 3137–3141 Occurrence Handle10.1001/jama.259.21.3137 Occurrence Handle1:STN:280:BieB3MrhsFQ%3D Occurrence Handle3367489
T Diamond L Nery I Hales (1991) ArticleTitleA therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone density measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab 72 1184–1188 Occurrence Handle1:STN:280:By6B38rhvVw%3D Occurrence Handle2026740
J Lehmke U Bogner D Felsenberg H Peters H Schleusener (1992) ArticleTitleDetermination of bone mineral density by qualitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women. Clin Endocrinol 36 511–517 Occurrence Handle1:CAS:528:DyaK38XksVGrtrg%3D
DC Gonzalez CA Mautalen PH Correa E el-Tamer S el-Tamer (1991) ArticleTitleBone mass in totally thyroidectomized patients. Role of calcitonin deficiency and exogenous thyroid treatment. Acta Endocrinol 124 521–525 Occurrence Handle1:STN:280:By6B38fmvFQ%3D Occurrence Handle2028710
JJ Stepan Z Limanova (1992) ArticleTitleBiochemical assessment of bone loss in patients on long-term thyroid hormone treatment. Bone Miner 17 377–388 Occurrence Handle1:STN:280:By2A38zivFA%3D Occurrence Handle1623331
C Marcocci F Golia G Bruno-Bossio E Vignali A Pinchera (1994) ArticleTitleCarefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab 78 818–823 Occurrence Handle1:STN:280:ByuB3cbjs1A%3D Occurrence Handle8157704
M Garton I Reid N Loveridge S Robins L Murchison G Beckett D Reid (1994) ArticleTitleBone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy. Clin Endocrinol 41 747–755 Occurrence Handle1:STN:280:ByqC1MnjtF0%3D
C Marcocci F Golia E Vignali A Pinchera (1997) ArticleTitleSkeletal muscle integrity in men chronically treated with suppressive doses of L-thyroxine. J Bone Miner Res 12 72–77 Occurrence Handle1:CAS:528:DyaK2sXotlWrtQ%3D%3D Occurrence Handle9240728
DC Bauer MC Nevitt B Ettinger K Stone (1977) ArticleTitleLow thyrotropin levels are not associated with bone loss in older women: a prospective study. J Clin Endocrinol Melab 82 2931–2936
J Franklyn J Betteridge R Holder J Daykin J Lilley M Sheppard (1994) ArticleTitleBone mineral density in thyroxine-treated females with or without a previous history of thyrotoxicosis. Clin Endocrinol 41 425–432 Occurrence Handle1:STN:280:ByqD2czks1I%3D
J Faber AM Galloe (1994) ArticleTitleChanges in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta analysis. Eur J Endocrinol 130 350–356 Occurrence Handle1:STN:280:ByuB3MvmsVA%3D Occurrence Handle8162163
B Uzzan J Campos M Cucherat P Nony JP Boissel GY Perret (1996) ArticleTitleEffects on bone mass of long-term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81 4278–4289 Occurrence Handle1:CAS:528:DyaK28XnsVKktbw%3D Occurrence Handle8954028
FW Hanna RJ Pettit F Animari WD Evans D Sandeman JH Lazarus (1998) ArticleTitleEffect of replacement doses of thyroxine on bone mineral density. Clin Endocrinol 48 229–234 Occurrence Handle1:STN:280:DyaK1c3ktVCjsg%3D%3D
J Leger JC Ruiz J Guibourdenche C Kindermans M Garabedian P Czemichow (1997) ArticleTitleBone mineral density and metabolism in children with congenital hypothyroidism after prolonged L-thyroxine therapy. Acta Paediatr 86 704–710 Occurrence Handle1:STN:280:ByiA1c3ovVI%3D Occurrence Handle9240877
C Ribot F Tremollieres JM Pouilles JP Louvet (1990) ArticleTitleBone mineral density and thyroid hormone therapy. Clin Endocrinol 33 143–153 Occurrence Handle1:STN:280:By6D3s%2FgsVY%3D
BL Solomon L Wartofsky KD Burman (1993) ArticleTitlePrevalence of fractures in postmenopausal women with thyroid disease. Thyroid 3 17–23
MC Sheppard R Holder JA Franklyn (2002) ArticleTitleLevothyroxine treatment and occurrence of fracture of the hip. Arch Intern Med 162 338–343 Occurrence Handle10.1001/archinte.162.3.338 Occurrence Handle1:CAS:528:DC%2BD38XitVGgu78%3D Occurrence Handle11822927
GP Leese RT Jung C Guthrie N Waugh MC Browning (1992) ArticleTitleMorbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol 37 500–503 Occurrence Handle1:STN:280:ByyC287lslU%3D
P Vestergaard J Weeke HC Hoeck HK Nielsen J Rungby L Rejnmark P Laurberg L Mosekilde (2000) ArticleTitleFractures in patients with primary idiopathic hypothyroidism. Thyroid 10 335–340 Occurrence Handle1:STN:280:DC%2BD3c3msFensA%3D%3D Occurrence Handle10807062
P Vestergaard L Mosekilde (2002) ArticleTitleFractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid 12 411–419 Occurrence Handle10.1089/105072502760043503 Occurrence Handle12097203
CG Muller TA Bayley JE Harrison R Tsang (1995) ArticleTitlePossible limited bone loss with suppressive thyroxine therapy is unlikely to have clinical relevance. Thyroid 5 81–87 Occurrence Handle1:STN:280:ByqA2srlsFc%3D Occurrence Handle7647577
CY Guo AP Weetman R Eastell (1997) ArticleTitleLongitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Clin Endocrinol 46 301–307 Occurrence Handle1:CAS:528:DyaK2sXjt1enuro%3D
AWC Kung SSC Yeung (1996) ArticleTitlePrevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin. J Clin Endocrinol Metab 81 1232–1236 Occurrence Handle1:CAS:528:DyaK28Xhs1agt7g%3D Occurrence Handle8772604
DL Schneider EL Barrett-Connor DJ Morton (1994) ArticleTitleThyroid hormone use and bone mineral density in elderly women. Effect of estrogen. JAMA 271 1245–1249 Occurrence Handle10.1001/jama.271.16.1245 Occurrence Handle1:CAS:528:DyaK2cXkt1Ont7Y%3D
HN Rosen AC Moses C Gundberg VT Kung SM Seyedin T Chen M Holick SL Greenspan (1993) ArticleTitleTherapy with parental pamidronate prevents thyroid hormone-induced bone turnover in humans. J Clin Endocrinol Metab 77 664–669 Occurrence Handle1:CAS:528:DyaK2cXmvFantw%3D%3D Occurrence Handle8370687
H Rosen A Moses J Garber DS Ross SL Lee L Ferguson V Chen K Lee SL Greenspan (1998) ArticleTitleRandomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate. J Clin Endocrinol Metab 83 2324–2330
G Lupoli V Nuzzo C Di-Carlo P Affinito M Vollery G Vitale E Cascone F Arlotta C Nappi (1996) ArticleTitleEffects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole. Gynecol Endocrinol 10 343–348
Acknowledgements
This work was supported by OTKA grant T-35215 (Hungary).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lakatos, P. Thyroid Hormones: Beneficial or Deleterious for Bone? . Calcif Tissue Int 73, 205–209 (2003). https://doi.org/10.1007/s00223-002-0027-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-002-0027-8